Towercrest Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Hold |
9,225
| – | – | 0.17% | 51 |
|
|
2026
Q1 | $1.11M | Sell |
9,225
-21
| -0.2% | -$2.42K | 0.17% | 52 |
|
|
2025
Q4 | $973K | Buy |
9,246
+45
| +0.5% | +$4.22K | 0.15% | 56 |
|
|
2025
Q3 | $772K | Buy |
9,201
+76
| +0.8% | +$6.26K | 0.12% | 60 |
|
|
2025
Q2 | $722K | Sell |
9,125
-20
| -0.2% | -$1.59K | 0.13% | 55 |
|
|
2025
Q1 | $821K | Hold |
9,145
| – | – | 0.16% | 48 |
|
|
2024
Q4 | $910K | Sell |
9,145
-36
| -0.4% | -$3.71K | 0.15% | 52 |
|
|
2024
Q3 | $1.04M | Hold |
9,181
| – | – | 0.17% | 53 |
|
|
2024
Q2 | $1.14M | Sell |
9,181
-189
| -2% | -$24.3K | 0.19% | 49 |
|
|
2024
Q1 | $1.24M | Buy |
9,370
+499
| +6% | +$61.5K | 0.21% | 48 |
|
|
2023
Q4 | $967K | Sell |
8,871
-15
| -0.2% | -$1.56K | 0.17% | 50 |
|
|
2023
Q3 | $915K | Buy |
8,886
+35
| +0.4% | +$3.77K | 0.18% | 53 |
|
|
2023
Q2 | $1.02M | Buy |
8,851
+36
| +0.4% | +$4.09K | 0.19% | 51 |
|
|
2023
Q1 | $938K | Buy |
8,815
+7
| +0.1% | +$756 | 0.2% | 50 |
|
|
2022
Q4 | $977K | Hold |
8,808
| – | – | 0.22% | 49 |
|
|
2022
Q3 | $759K | Hold |
8,808
| – | – | 0.18% | 50 |
|
|
2022
Q2 | $803K | Hold |
8,808
| – | – | 0.18% | 50 |
|
|
2022
Q1 | $723K | Hold |
8,808
| – | – | 0.14% | 55 |
|
|
2021
Q4 | $675K | Sell |
8,808
-50
| -0.6% | -$3.98K | 0.12% | 54 |
|
|
2021
Q3 | $665K | Buy |
8,858
+972
| +12% | +$73.9K | 0.13% | 55 |
|
|
2021
Q2 | $613K | Sell |
7,886
-379
| -5% | -$28.2K | 0.12% | 53 |
|
|
2021
Q1 | $608K | Sell |
8,265
-1,407
| -15% | -$104K | 0.13% | 50 |
|
|
2020
Q4 | $755K | Hold |
9,672
| – | – | 0.17% | 48 |
|
|
2020
Q3 | $766K | Hold |
9,672
| – | – | 0.19% | 47 |
|
|
2020
Q2 | $714K | Hold |
9,672
| – | – | 0.19% | 48 |
|
|
2020
Q1 | $710K | Sell |
9,672
-1,217
| -11% | -$95.6K | 0.21% | 49 |
|
|
2019
Q4 | $945K | Buy |
10,889
+3,268
| +43% | +$268K | 0.24% | 47 |
|
|
2019
Q3 | $612K | Hold |
7,621
| – | – | 0.17% | 49 |
|
|
2019
Q2 | $609K | Buy |
7,621
+472
| +7% | +$36.1K | 0.17% | 49 |
|
|
2019
Q1 | $567K | Sell |
7,149
-440
| -6% | -$32.9K | 0.16% | 49 |
|
|
2018
Q4 | $553K | Hold |
7,589
| – | – | 0.18% | 50 |
|
|
2018
Q3 | $514K | Hold |
7,589
| – | – | 0.15% | 53 |
|
|
2018
Q2 | $440K | Buy |
+7,589
| New | +$428K | 0.14% | 61 |
|
Other funds holding MRK
Towercrest Capital Management's MRK Position: Q2 2026 in Review
Towercrest Capital Management held its Merck (MRK) position steady in Q2 2026 at 9,225 shares worth $1.19M. The position accounts for 0.17% of the portfolio, ranked #51.
Towercrest Capital Management first reported a position in MRK in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.24M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Towercrest Capital Management held 9,225 shares of Merck worth $1.19M as of Q2 2026.
- Towercrest Capital Management left its Merck share count unchanged in Q2 2026.
- Merck made up 0.17% of Towercrest Capital Management's portfolio in Q2 2026, its #51 holding.
- Towercrest Capital Management first reported a position in Merck in Q2 2018 and has held it in 33 quarters since.
- Towercrest Capital Management's Merck position peaked at $1.24M in Q1 2024.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Towercrest Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.